from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1063c/-

LFCtreatmentdescriptionclass of inhibitor

-0.714

Amikacinug/mL Amikacintranslation

-0.461

Cap5-10ug/mL Capreomycintranslation

-0.593

Rox10-50 ug/mL Roxithromycintranslation

-0.675

SM2-5 ug/mL Streptomycintranslation

-0.820

Tet5-10 ug/mL Tetracyclinetranslation

0.211

Rif0.2-5ug/mL Rifampicintranscription

-0.280

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.520

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.707

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.061

CPZ10-50 ug/mL Chlorpromazinerespiration

0.061

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.011

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.646

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.440

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.605

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.106

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.663

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.023

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.713

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.532

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.818

KCN5-20 ug/mL Potassium cyaniderespiration

-0.244

NaN30.2-2 mM Sodium aziderespiration

-0.257

Nigericin50 uM Nigericinrespiration

1.182

TRC10-150 ug/mL Triclosanrespiration

1.185

TRZ10-25 ug/mL Thioridazinerespiration

-0.573

Valinomycin0.5-10 uM Valinomycinrespiration

-2.217

ZnSO42 mM ZnSO4respiration

-0.497

menadione6-10 ug/mL Menadionerespiration

-0.362

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.334

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.442

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.774

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.505

NRP_1Non-replicating persistence stage 1dosRassociated

-0.596

Amp0.2mg/mL AmpicillincellWall

-0.391

Cephalexin20-100 ug/mL CephalexincellWall

-0.361

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.661

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.789

EMB10-20 ug/mL EthambutolcellWall

-0.246

Eta12-40 ug/mL EthionamidecellWall

-0.381

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.153

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.394

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.399

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.739

BZA0.12 mg/mL BenzamidearomaticAmides

0.791

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.734

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.406

H2O24 mM hydrogen peroxideDNAdamaging

-0.363

Levo10 ug/mL LevofloxacinDNAdamaging

-0.446

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.432

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.546

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.658

UVUV-irradiationDNAdamaging

-0.099

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.192

Antimycin12.5-50 ug/mL Antimycin A?

-0.456

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.011

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.441

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.586

PA8240.2-2 ug/mL PA-824?

0.985

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.498

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.489

Verapamil50 uM Verapamil?

-0.532

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.525

methoxatin10-20 ug/mL Methoxatin?